JNJ
JOHNSON & JOHNSON
NYSE · Healthcare · Drug Manufacturers - General · US
$275.20
+1.53%Margins
Gross margin
68.8%
EBITDA margin
31.0%
EBIT margin
25.7%
Net margin
16.2%
FCF margin
20.7%
19.7%
Return on equity
8.2%
Return on assets
20.2%
Return on invested capital
0.50x
Asset turnover
$26.2B
Cash from operations
$7.16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026